Nucleus has listed on the Alternative Investment Market (AIM) at an expected market capitalisation of £140m.
Dealing on the platform company's shares begun at 8am on Thursday at a placing price of 183p. The gross proceeds of the listing receivable by the selling shareholders could be more than £32m. The firm, which has more than £14bn assets under administration, said 22.9% of the issued ordinary share capital was sold pursuant to the placing. "This is an important milestone as we continue our work to support and promote the strategic alignment of advisers and their customers," said chief executive David Ferguson. "It's great to see so many institutional investors believing in the growth...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes